quality of care

Research in Review

Menopausal Symptoms Wrongly Attributed to Tamoxifen Dampen Adherence Rates

12/13/2016

JCP Editors

Menapausal symptoms experienced by women with breast cancer that were wrongly attributed to side effects of tamoxifen treatment had a dampening effect on medication adherence, according to a new...

...

12/13/2016

Journal of Clinical Pathways

Interview

Clinical Pathways Through Quality Metrics: ASCO Quality Oncology Practice Initiative

12/13/2016

JCP Editors

The delivery of cancer care in the United States is rapidly evolving. Approximately 70% of US patients with cancer are treated at community oncology centers, but it has become increasingly common for stand-alone...

The...

12/13/2016

Journal of Clinical Pathways

Research in Review

Insurance Expansion Improves Resection Rates Among Patients with Colorectal Cancer

12/13/2016

JCP Editors

The implementation of health care reform in Massachusetts increased surgical resection rates for colorectal cancer and decreased the likelihood of emergent resection, suggesting that insurance expansion may improve...

The...

12/13/2016

Journal of Clinical Pathways

Research in Review

High-Intensity End-of-Life Care Common Among Pediatric Cancer Patients

12/13/2016

JCP Editors

Children with cancer frequently receive high-intensity end-of-life care, despite advances in palliative medicine, according to the results of a retrospective study published in Journal of Clinical...

...

12/13/2016

Journal of Clinical Pathways

Research in Review

Few RCTs of New Systemic Therapies Met ESMO Guidelines for Meaningful Outcomes

12/13/2016

JCP Editors

Fewer than one-third of randomized controlled trials reporting statistically significant outcomes for novel systemic therapies in solid cancers met the European Society of Medical Oncology’s (ESMO) threshold for...

Fewer...

12/13/2016

Journal of Clinical Pathways

Research in Review

Switching From Docetaxel to Paclitaxel and Bevacizumab Improves PFS in NSCLC

12/08/2016

JCP Editors

Patients with non-squamous non-small cell lung cancer (NSCLC) have improved progression-free survival (PFS) if they switch from docetaxel to paclitaxel and bevacizumab treatments, according to new...

...

12/08/2016

Journal of Clinical Pathways

Research in Review

Surgery Better Than Neoadjuvant Chemo for Epithelial Ovarian Cancer

11/23/2016

JCP Editors

Primary cytoreductive surgery (PCS) is better than neoadjuvant chemotherapy (NACT) for overall survival in women aged 70 years or younger with advanced-stage epithelial ovarian cancer (EOC), according to a recent...

...

11/23/2016

Journal of Clinical Pathways

Research in Review

Testing for PD-L1 Expression to Determine Lung Cancer Treatment

11/17/2016

JCP Editors

Using PD-L1 expression to determine non-small cell lung cancer (NSCLC) treatment is becoming standard of care, according to a presentation given at the 11th Annual New York Lung Cancer Symposium (November 12,...

Using...

11/17/2016

Journal of Clinical Pathways

Research in Review

Combining Targeted Therapies Provides Optimal Treatment for CML

11/17/2016

JCP Editors

Using mathematical modeling, researchers have determined the best combination and sequencing of targeted therapies for the treatment of chronic myeloid leukemia (CML). Their results have been published in PLOS...

Using...

11/17/2016

Journal of Clinical Pathways

Research in Review

New Treatment Effective for B-Cell Precursor ALL in Pediatric Patients

11/17/2016

JCP Editors

Single-agent blinatumomab demonstrated antileukemia activity in pediatric patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (BCP-ALL), according to a study published in the Journal of...

...

11/17/2016

Journal of Clinical Pathways